Searched for
INDIA CHOLESTEROL DATA
India, China bore one-third of global 'bad' cholesterol burden in 2023: StudyHigh LDL cholesterol caused 3.6 million deaths globally in 2023. India and China bore one-third of this worldwide disease burden. The numbe...- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- 'All Indians from age 17 must take this test': Narayana Health founder Dr. Devi Shetty explains why so many young people are dying of heart attacksDr. Devi Shetty Heart Attack Prevention Tests: Sudden collapses among young Indians are preventable, according to Dr. Devi Shetty. Accordin...
- India-US trade deal "75 years overdue"; proposed 12.5% tariff part of talks: USIBC's Atul KeshapUS-India Business Council President Atul Keshap believes a trade deal is close. He notes ongoing talks and a US tariff proposal are part of...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- India’s heart-risk score in diabetes: Why every Indian must pay attention - A World Heart Month specialIn India, individuals with diabetes face a significant risk of cardiovascular disease, necessitating proactive heart health management. Too...
- Heart pill sales explode 50% in 5 years: What’s fueling India’s cardiac crisis?Heart disease is on the rise in India. Sales of heart medicines have increased significantly. This growth is attributed to better awareness...
- Heart of the matter: Sales of cardiac drugs beat strongerHeart disease is increasing in India. This is boosting sales of cardiac drugs. Sales have risen nearly 50% in five years. Younger people ar...
- Novartis offers payment plan for high-cost heart medicineNovartis introduces a financing scheme with Pine Labs for its cholesterol-lowering drug, Sybrava (inclisiran), in India, aiming to broaden ...
- 45% of Indians ‘unhealthy’ in 2023: GOQii India Fit ReportA new report reveals concerning health trends in India, with 45% of the population categorized as "unhealthy" in 2023. The GOQii India Fit ...
- Lipid Association of India issues new updated heart disease guidelines for Indian patientsLAI has been advocating for regular lipid profile screenings from the age of 20, and from the age of two for those with a family history of...
- Five in 10 employees have faced depression, emotional or anxiety-related symptoms: ekincareThe most common mental health issues plaguing corporate India are depression, emotional turmoil, insomnia and anxiety, respectively. Men ar...
- World Heart Day: 6 in 10 Indians have abnormal levels of bad cholesterol, study reveals Vadodara has lowest heart disease risk, Bengaluru highestThe study was conducted on 2.66 million people of ages 20 and above across 250 cities.
- Sun Pharma to launch first-in-class oral lipid-lowering drug in IndiaThe Mumbai-based drug major said one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India ...
- Search for vaccines hots up as Covid-19 continues to spread and wreak havoc around the worldOxford University and AstraZeneca will be sharing their data from phase-I trial of their much-touted Covid-19 vaccine candidate on July 20....
- Blood pressure, diabetes, smoking among biggest killers in India: StudyHigh blood pressure and blood sugar, smoking and pollution are causing more deaths in India than under-nutrition and tropical diseases.
- Daily 'super pill' to prevent heart attacks and strokesThe largest ever analysis on the use of a polypill in cardiovascular disease shows potential for improvements in patient care, researchers ...
- New US norms on statins to help Indian drug firmsCholesterol-reducing drugs worth nearly $15 billion (Rs 92,000 crore) were sold in the US in the year to September 2013, Bakhru wrote in hi...
- Lupin gets USFDA nod for additional strengths of cholesterol drug"Lupin Pharmaceuticals Inc (LPI), the company's US subsidiary would commence marketing the product shortly," Lupin said.
Load More
